Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|---|---|---|
| Net sales | revenue | 5.32B | 8.41% |
| Gross profit | profit | 3.23B | 8.00% |
| Cost of sales | cost | 2.10B | 9.04% |
| Interest income | revenue | 16.00M | 6.67% |
| Operating profit | profit | 964.00M | -10.41% |
| Selling, general and administrative expenses | cost | 2.08B | 9.38% |
| Other operating income (expense), net | revenue | 186.00M | 1330.77% |
| Aggregate | revenue | 980.00M | -10.17% |
| Income before income taxes | profit | 892.00M | -6.40% |
| Interest expense | cost | 62.00M | -6.06% |
| Non-service related postretirement costs | cost | 26.00M | -63.89% |
| Net income including noncontrolling interests | profit | 681.00M | -6.20% |
| Provision for income taxes | cost | 211.00M | -7.05% |
| Net income attributable to colgate-palmolive company | profit | 646.00M | -6.38% |
| Less: net income attributable to noncontrolling interests | cost | 35.00M | -2.78% |
| Segment | Value | YoY |
|---|---|---|
| Oral, Personal and Home Care | 4.13B | 8.94% |
| Hill’s Pet Nutrition | 1.19B | 6.80% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Cost | assets | 10.89B | |
| Current inventories, net | assets | 2.09B | |
| Receivables (net of allowances of $89 and $90, respectively) | assets | 1.89B | |
| Cash and cash equivalents | assets | 1.33B | |
| Other current assets | assets | 772.00M | |
| Accumulated depreciation, depletion and amortization, property, plant, and equipment | assets | 6.26B | |
| Total current assets | assets | 6.08B | |
| Property, plant and equipment, net | assets | 4.62B | |
| Goodwill | assets | 3.11B | |
| Intangible assets, net (excluding goodwill) | assets | 1.52B | |
| Other assets | assets | 1.07B | |
| Deferred income tax assets, net | assets | 211.00M | |
| Total assets | assets | 16.61B | |
| Total liabilities | liabilities | 16.12B | |
| Total equity | liabilities | 486.00M | |
| Long-term debt, excluding current maturities | liabilities | 7.94B | |
| Total current liabilities | liabilities | 5.93B | |
| Other liabilities | liabilities | 2.06B | |
| Deferred income tax liabilities, net | liabilities | 198.00M | |
| Noncontrolling interests | liabilities | 341.00M | |
| Total colgate-palmolive company shareholders’ equity | equity | 145.00M | |
| Treasury stock, common, value | equity | 28.66B | |
| Accumulated other comprehensive income (loss) | equity | 3.87B | |
| Other accruals | liabilities | 3.36B | |
| Accounts payable | liabilities | 2.10B | |
| Accrued income taxes, current | liabilities | 444.00M | |
| Debt payable within one-year | liabilities | 36.00M | |
| Aggregate | equity | 32.67B | |
| Retained earnings | equity | 26.82B | |
| Additional paid-in capital | equity | 4.39B | |
| Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued) | equity | 1.47B |
| Item | Value |
|---|---|
| Net income including noncontrolling interests | 681.00M |
| Restructuring and termination benefits, net of cash | 165.00M |
| Depreciation and amortization | 156.00M |
| Share-based payment arrangement, noncash expense | 40.00M |
| Increase (decrease) in other noncurrent assets | 19.00M |
| Accounts payable and other working capital | -11.00M |
| Deferred income taxes | -18.00M |
| Other non-current assets | -29.00M |
| Increase (decrease) in inventories | -41.00M |
| Increase (decrease) in receivables | -215.00M |
| Item | Value |
|---|---|
| Proceeds from sale of marketable securities and investments | 94.00M |
| Payment for (proceeds from) other investing activity | -8.00M |
| Payments to acquire marketable securities | -70.00M |
| Payments to acquire productive assets | -138.00M |
| Item | Value |
|---|---|
| Short-term borrowing (repayment) less than 90 days, net | 1.14B |
| Proceeds from exercise of stock options | 127.00M |
| Other financing activities | -23.00M |
| Payments for repurchase of common stock | -306.00M |
| Payments of ordinary dividends | -417.00M |
| Repayments of other debt | -1.08B |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 1.29B |
| Cash and cash equivalents, end of period | 1.33B |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support